Biomerica, Inc.

BMRA·NasdaqCM
Compare
1.8350−0.0002 (−0.01%)today
At close: Oct 12, 4:00 PM EDT · May be delayed up to 15 min · USD

Prices may be delayed up to 15 min. Not investment advice. News volume: articles in the 4Search index each day.

Key statistics

Previous close1.8352
Open1.9000
Day range1.83501.9000
52-week range1.45003.2100
Off day high−3.42%
Off 52-week high−42.83%
Volume5.02K
Avg. volume (3M)70.95K
Market cap8.44M
EPS (TTM)-1.30
Forward P/E4.71
P/E ratio (TTM)—
Dividend yield—
Beta (5Y)—
Shares outstanding4.60M
Short interest—
Earnings dateAug 26, 2025 (est.)
Analyst target—
Profit margin—

Against its peers

Compare in full ›
BMRA TRIB AIDX INBS CODX RPID
Market cap 8.44M 5.33M 4.67M 5.01M 8.73M 44.08M
P/E (TTM) — — — — — —
Forward P/E 4.7 -6.4 — 4.3 -1.5 -1.2
Price/book 2.2 -0.1 2.8 0.8 0.5 2.5
Dividend yield — — — — — —
1-year change −36.11% −78.83% −98.45% −85.70% −88.80% −74.38%
Today −0.01% −4.30% −2.40% −1.31% +11.61% −1.65%

The closest companies by business and industry (Medical Devices). Prices may be delayed up to 15 min.

Latest news

All BMRA news ›
Stock Titan·

[EFFECT] BIOMERICA INC SEC Filing

Biomerica, Inc. (NASDAQ: BMRA) develops, manufactures and markets advanced diagnostic-guided IBS tests, rapid screening kits and CDMO services worldwide. [EFFECT] BIOMERICA INC SEC Filing Sentiment and the balance of points Rhea-AI…

Markets Daily·Positive

Analyzing Boston Scientific (NYSE:BSX) and Biomerica (NASDAQ:BMRA)

Posted by Mitch Edgeman on Oct 4th, 2026 Biomerica (NASDAQ:BMRA – Get Free Report) and Boston Scientific (NYSE:BSX – Get Free Report) are both healthcare companies, but which is the superior investment? We will compare the two businesses…

Stock Titan·

Biomerica sells 1.39M shares at $1.60 each

Intermap Completes Acquisition of PCI Geomatics The amended disclosures include a private placement with approximately $2.23 million in gross proceeds and a $500,000 note linked to a Diagnosis S.A. investment sale. For The Fiscal Year…

Stock Titan·

Biomerica registers 1.4M shares for resale

$2.6 Trillion and Climbing: Where the AI Spending Is Going The shares stem from a private placement and consulting compensation, while Biomerica receives no proceeds from stockholder resales. The incorporated audit report includes an…

From articles in the 4Search news index.

In the news

5mentions in 30 days
5with it in the headline
Positivesentiment

Finance and business coverage in the 4Conservative news index: articles that name it in the headline, or in the text beside its ticker. Sentiment is the index's own reading of the latest 5 articles, not a forecast.

Market data is provided for information only and comes from free public sources. Prices may be delayed up to 15 minutes; data may be incomplete or inaccurate. Nothing on this page is investment advice or a recommendation to buy or sell any security. News and coverage analytics are drawn from the 4Conservative index. Terms of use.